NCT06216067

Brief Summary

The goal of this clinical trial is to evaluate two separate operating room cataract measuring tools in predicting the residual astigmatism (prediction error) in patients with corneal astigmatism. The main question it aims to answer is: Show the refractive predictability comparing the use of Operating Room cataract toric lens placement tools against the standard manual technique. Participants will be implanted with the TECNIS Toric II IOL Lens Model ZCU; the second eye, if applicable, is to be implanted within 45 days of the first-eye surgery. Researchers will compare two Operating Room cataract lens placement tools: the Zeiss CALLISTO vs. the Wavetec AnalyzOR to determine refractive predictability.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 14, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 21, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 21, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 20, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 22, 2024

Completed
Last Updated

January 22, 2024

Status Verified

January 1, 2024

Enrollment Period

1.6 years

First QC Date

December 20, 2023

Last Update Submit

January 11, 2024

Conditions

Keywords

cataracttoriccataract surgeryresidual astigmatism

Outcome Measures

Primary Outcomes (1)

  • Diopters of Residual Cylinder

    Diopters of Residual Cylinder at Month 1 with an upper boundary and lower boundary of +0.50 D and - 0.50 D

    1 Month postoperatively from implantation of intraocular lens

Secondary Outcomes (5)

  • Accuracy of Residual Astigmatism (Predictive Error)

    Month 1

  • Refractive predictability of the IOL (absolute difference between MRSE and target MRSE)

    Month 1

  • Uncorrected Distance Visual Acuities Achieved - Snellen

    Month 1

  • Procedure and Operating Room Time

    Procedure time (up to 2 minutes)

  • Operating Room Time

    Operating Room Time (up to 30 minutes)

Study Arms (2)

Group 1 (Operating Room #1) CALLISTO eye

Group 1 (Operating Room #1) will have preoperative measurements with the IOL Master 700 and lens selection will be based on Veracity. The subjects in group 1 will have LenSx surgery and placement of the lens will be based on the CALLISTO eye.

Device: CALLISTO eye

Group 2 (Operating Room #2) Wavetec AnalyzOR

Group 2 (Operating Room #2) will also have preoperative measurements with the IOL Master700, but lens selection will be based on the Wavetec AnalyzOR. The subjects in group 2 will have LenSx surgery and placement of the lens will be based on the Wavetec AnalyzOR.

Device: Wavetec AnalyzOR

Interventions

Cataract toric lens placement tool

Group 1 (Operating Room #1) CALLISTO eye

Cataract toric lens placement tool

Group 2 (Operating Room #2) Wavetec AnalyzOR

Eligibility Criteria

Age55 Years - 87 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients undergoing unilateral or bilateral cataract extraction

You may qualify if:

  • Unilateral or bilateral cataract extraction with single piece hydrophobic acrylic posterior capsular intraocular lens correcting astigmatism.
  • Clear intraocular media other than cataract.
  • Willing and able to complete all required postoperative visits.
  • Able to comprehend and sign a statement of informed consent in English.

You may not qualify if:

  • Ocular disease or pathology that, in the opinion of the Investigator, will affect the post-operative visual acuity and manifest refraction.
  • Prior intraocular or corneal refractive surgery, corneal transplant, or retinal detachment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chesapeake Eye Care and Laser Center, LLC

Annapolis, Maryland, 21401, United States

Location

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Officials

  • Maria C. Scott

    Chesapeake Eyecare and Laser Center, LLC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Maria C. Scott, MD

Study Record Dates

First Submitted

December 20, 2023

First Posted

January 22, 2024

Study Start

December 14, 2021

Primary Completion

July 21, 2023

Study Completion

July 21, 2023

Last Updated

January 22, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations